Boryung Corporation (KRX: 003850)

Market Cap	776.56B
Revenue (ttm)	928.72B
Net Income (ttm)	64.58B
Shares Out	65.87M
EPS (ttm)	979.10
PE Ratio	12.04
Forward PE	11.66
Dividend	100.00 (0.85%)
Ex-Dividend Date	n/a

Volume	774,656
Open	11,470
Previous Close	11,450
Day's Range	11,330 - 11,830
52-Week Range	8,720 - 13,750
Beta	0.63
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About Boryung

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1957
• Employees: 1,533
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003850

Financial Performance

In 2023, Boryung's revenue was 859.63 billion, an increase of 13.04% compared to the previous year's 760.48 billion. Earnings were 40.20 billion, a decrease of -4.04%.